arrow
K

Kathy Mulgrew

medimmune
H指数:18
被引数:2,377

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design

通过突触门控和亲和力调谐的三特异性抗体设计改善T细胞接合剂的双靶向选择性

MABS
IF7.3
2025-12-310
PRE
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release

IL-2-armored肽-主要组织相容性I类双特异性抗体重定向抗病毒效应记忆CD8 T细胞以诱导有效的抗癌细胞毒活性和有限的细胞因子释放

MABS
IF7.3
2024-08-280
OAAI
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment

ATR抑制剂ceralasertib通过调节肿瘤微环境来增强癌症检查点免疫治疗

2024-02-248
OAAI
Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer
2021-08-1653
OA
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown
2021-07-0651
OA
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells

增强PD-1活化T细胞CTLA4阻断的单价双特异性PD-1/CTLA4抗体的设计和功效

2021-01-08123
PRE
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein
2018-04-3036
OAAI
Antibody-drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads alter the tumor immune microenvironment and synergize with multiple immunotherapies
2017-07-011
PRE
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

带有吡咯并苯并二氮杂或微管溶素有效载荷的抗体-药物结合物具有免疫调节作用,并与多种免疫疗法协同作用

2017-05-1484
OAAI
Targeting CD73 in the tumor microenvironment with MEDI9447
2016-07-11247
OAAI